Navigation Links
KaloBios Provides Clinical Update and Reports Second Quarter Financial Results
Date:8/7/2014

that study in subjects with hematologic malignancies is fully enrolled with dosing ongoing. KaloBios initiated the Phase 2 expansion portion of the study focused on patients with certain EphA3 positive hematologic malignancies in 2014.
  • KB003 is an anti-GM-CSF mAb with potential to treat inflammatory diseases that was being developed for the treatment of severe asthma. In early 2014, KaloBios completed a Phase 2 clinical study in 160 patients with severe asthma which did not meet its primary endpoint of improvement in FEV1 from baseline as compared to placebo. As a result, KaloBios discontinued development of this compound in severe asthma, and is continuing to analyze the Phase 2 data to review with thought leaders. KaloBios is currently evaluating other possible indications in order to determine next steps, if any, in the development of KB003.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered® technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

    For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

    Forward Looking Statements
    This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and statements regarding the company's clinical development of KB001-A, KB004 and KB003. Forward-looking statements refle
    '/>"/>

    SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. KaloBios Provides Update on KB001-A Partnership and Clinical Status
    2. KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
    3. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
    4. KaloBios Elects Laurie Smaldone Alsup, M.D. to Board
    5. KaloBios to Present at Leerink Swann Rare Disease Roundtable
    6. KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock
    7. Herb C. Cross to Join KaloBios as Chief Financial Officer
    8. KaloBios KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
    9. KaloBios to Present at Stifel Healthcare Conference 2013
    10. KaloBios Reports First Quarter 2013 Financial Results
    11. KaloBios to Present at Needham Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... South Africa , Jan. 23, 2015   Leatt ... of personal protective equipment for all forms of sports, ... flagship Leatt-Brace® neck brace, announced today that the UISP ... federation, now requires all riders to wear a neck ...
    (Date:1/23/2015)... plc (NYSE: MNK ) announced today that ... program. The open-ended authorization permits the company to repurchase ... "Funding additional initiatives and seeking attractive ... to pursue a range of focused growth strategies," said ...
    (Date:1/23/2015)... and BOSTON , January 23, ... drug discovery and development company, is delighted to announce that ... been awarded to Miles Congreve (Vice President of ... and Malcolm Weir (Chief Executive Officer and co-founder) ...
    Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
    ... MUMBAI, India, Jan. 11 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: ... of Taro Pharmaceutical Industries Ltd. (Taro) regarding the outcome at the Annual ... The full text of Sun,s letter to Directors of Taro appears below: ... Arye Barak, Heather Douglas, Esq., ...
    ... , VIENNA, Va., Jan. 11 CEL-SCI Corporation (NYSE ... developer of vaccines and therapeutics for the prevention and treatment ... of all critical utilities and manufacturing equipment at its GMP ... a very important milestone as it allows CEL-SCI to move ...
    Cached Medicine Technology:Sun Pharmaceutical Sends Letter to Directors of Taro 2Sun Pharmaceutical Sends Letter to Directors of Taro 3Sun Pharmaceutical Sends Letter to Directors of Taro 4CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 2CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 3CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 4
    (Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
    (Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
    (Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
    (Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
    (Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
    Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
    ... -- The potential dangers of trampolines were highlighted recently when ... while jumping on a trampoline with his 5-year-old son, experts ... will spend six weeks in a cast. "Although trampolines ... a high risk for injuries, especially when two or more ...
    ... April 6 (HealthDay News) -- Anxiety improves a person,s ... new study. Smell is essential to animals in ... trigger powerful emotional responses in humans, the study authors ... of the University of Wisconsin-Madison exposed 14 young adults ...
    ... used routinely to measure heart function is being dramatically ... effective tests, according to a new study from the ... risk to the patient and significant extra cost," said ... professor of cardiovascular medicine and program director of Stanford,s ...
    ... The 24-hour internal clock controls many aspects of ... metabolism. Disruption in circadian rhythms leads to increased incidence ... cell of the body has its own internal timing ... another in check. One of these proteins, called ...
    ... April 6 (HealthDay News) -- Patients with digestive ... to significant levels of radiation from diagnostic imaging tests, ... from 2,590 patients with gastrointestinal disorders between 1999 ... had undergone diagnostic imaging tests such as computed tomography ...
    ... psychiatric impairments are common among long-term survivors of ... be assessed using a telephone-based test battery, according ... increasingly being recognized as an important outcome among ... long-term ALI survivors has not been assessed in ...
    Cached Medicine News:Health News:Experts Offer Advice After Yankee Pitcher's Trampoline Injury 2Health News:Invasive heart test being dramatically overused, Stanford study shows 2Health News:Invasive heart test being dramatically overused, Stanford study shows 3Health News:Coordinating the circadian clock: Molecular pair controls time-keeping and fat metabolism 2Health News:Diagnostic Scans Tied to Radiation Risk for Gastro Patients 2Health News:Long-term neuropsychological impairment is common in acute lung injury survivors 2
    The Electronic bag and bottle ventilator especially designed for your circle system needs. Provides the anaesthetist with a wide range of economic anaesthesia solutions with the following outstanding...
    A non-adhering hydrogel sheet dressing for use on all partial and full thickness wounds (excluding 3rd degree burns.) Hydrogel sheet contains 96% water and 4% insoluble cross-linked polyethylene oxid...
    ... OptiFlex SS is a complete physician preference ... inventory management system for all the supply ... The preference card system combined with a ... the entire case cart and operating suite ...
    Features various cylinder sizes and a simple two-handed pumping mechanism....
    Medicine Products: